<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="" /><meta name="keywords" content="Hypercalcaemia; Sodium chloride: infusion: hypercalcaemia; Bisphosphonates: hypercalcaemia; Corticosteroids: hypercalcaemia; Calcitonin: hypercalcaemia; Hyperparathyroidism; Cinacalcet; Hypercalciuria; Bendroflumethiazide: hypercalciuria" /><meta name="IX" content="Hypercalcaemia; Sodium chloride: infusion: hypercalcaemia; Bisphosphonates: hypercalcaemia; Corticosteroids: hypercalcaemia; Calcitonin: hypercalcaemia; Hyperparathyroidism; Cinacalcet; Hypercalciuria; Bendroflumethiazide: hypercalciuria" /><title>9.5.1.2 Hypercalcaemia and hypercalciuria: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP6106-hypercalcaemia-and-hypercalciuria.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP6106-hypercalcaemia-and-hypercalciuria.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP6106-hypercalcaemia-and-hypercalciuria.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 07 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP5812-nutrition-and-blood.htm">9 Nutrition and blood</a> &gt; <a href="PHP6083-minerals.htm">9.5 Minerals</a> &gt; <a href="PHP6084-calcium-and-magnesium.htm">9.5.1 Calcium and magnesium</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP6089-calcium-salts.htm" title="Previous: CALCIUM SALTS">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP6107-cinacalcet.htm" title="Next: CINACALCET">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1><span>9.5.1.2 </span>Hypercalcaemia and hypercalciuria</h1><?highlighter on?><div id="pC" class="jN"> <div><h2>Severe hypercalcaemia</h2><p>Severe hypercalcaemia calls for urgent treatment before detailed investigation of the cause. Dehydration should be corrected first with intravenous infusion of <strong>sodium chloride 0.9%</strong>. Drugs (such as thiazides and vitamin D compounds) which promote hypercalcaemia, should be discontinued and dietary calcium should be restricted.</p><p>If <em>severe hypercalcaemia persists</em> drugs which inhibit mobilisation of calcium from the skeleton may be required. The <strong>bisphosphonates</strong> are useful and disodium pamidronate (<a title=" Bisphosphonates" href="PHP4652-bisphosphonates-and-other-drugs-affecting-bone-metabolism.htm">section 6.6.2</a>) is probably the most effective.</p><p><strong>Corticosteroids </strong> (<a title=" Corticosteroids" href="PHP4326-corticosteroids.htm">section 6.3</a>) are widely given, but may only be useful where hypercalcaemia is due to sarcoidosis or vitamin D intoxication; they often take several days to achieve the desired effect.</p><p><strong>Calcitonin</strong> (<a title=" Calcitonin" href="PHP4645-calcitonin-and-parathyroid-hormone.htm">section 6.6.1</a>) is relatively non-toxic but its effect can wear off after a few days despite continued use; it is rarely effective where bisphosphonates have failed to reduce serum calcium adequately.</p><p>After treatment of severe hypercalcaemia the underlying cause must be established. <em>Further treatment</em> is governed by the same principles as for initial therapy. Salt and water depletion and drugs promoting hypercalcaemia should be avoided; oral administration of a bisphosphonate may be useful.</p></div> <div><h2>Hyperparathyroidism</h2><p><strong>Cinacalcet</strong> is licensed for the treatment of secondary hyperparathyroidism in dialysis patients with end-stage renal disease (but see NICE guidance below), for primary hyperparathyroidism in patients where parathyroidectomy is inappropriate, and for the treatment of hypercalcaemia in parathyroid carcinoma. Cinacalcet reduces parathyroid hormone which leads to a decrease in serum calcium concentrations.</p><p><strong>Paricalcitol</strong> (<a title="sub-section: Vitamin D" href="PHP6223-vitamin-d.htm">section 9.6.4</a>) is also licensed for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal failure.</p><p>Parathyroidectomy may be indicated for hyperparathyroidism.</p><div class="cI"><p class="cAE">NICE guidance</p><h3 class="cT">Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy (January 2007)</h3><p>Cinacalcet is not recommended for the routine treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy.</p><p>Cinacalcet is recommended for the treatment of refractory secondary hyperparathyroidism in patients with end-stage renal disease (including those with calciphylaxis) <strong>only</strong> in those:</p><ul><li><p>who have ‘very uncontrolled’ plasma concentration of intact parathyroid hormone (defined as greater than 85 picomol/litre) refractory to standard therapy, and a normal or high adjusted serum calcium concentration,<br /><strong>and</strong></p> </li><li><p>in whom surgical parathyroidectomy is contraindicated, in that the risks of surgery outweigh the benefits.</p> </li></ul><p>Response to treatment should be monitored regularly and treatment should be continued only if a reduction in the plasma concentration of intact parathyroid hormone of 30% or greater is seen within 4 months of treatment.</p></div></div> <div><h2>Hypercalciuria</h2><p>Hypercalciuria should be investigated for an underlying cause, which should be treated. Where a cause is not identified (idiopathic hypercalciuria), the condition is managed by increasing fluid intake and giving bendroflumethiazide in a dose of 2.5 mg daily (a higher dose is not usually necessary). Reducing dietary calcium intake may be beneficial but severe restriction of calcium intake has not proved beneficial and may even be harmful.</p></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_PHP6107-cinacalcet"><a href="PHP6107-cinacalcet.htm" title="CINACALCET">CINACALCET</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP6089-calcium-salts.htm">Previous: CALCIUM SALTS</a> | <a class="top" href="PHP6106-hypercalcaemia-and-hypercalciuria.htm#">Top</a> | <a accesskey="]" href="PHP6107-cinacalcet.htm">Next: CINACALCET</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>